redspeed: I fully understand that there are many variables that can influence the best laid plans of a CEO. I think the longs here have been very patient over the past 12 months and have overlooked missed milestones and zero increase in shareholder value from 11 months ago in January 2014.

I am willing to overlook no real fireworks going off in December other than hearing that ICON successfully complete the Validation Test and getting the updated LP002 data. I am not expecting any partnerships this month, or the RP orphan, or anything else, just the Lympro data.

Since Gerald is referring to December as Lympro's "Launch" date, I would hope we get some indication that pharmas are beginning to commit to using Lympro. That would be great news in December or the first couple weeks of january. But if we don't get any "concrete" catalysts like that by mid january at the JP Morgan Conference, and we just get the same ole same ole from Gerald.....he will have shot himself in the foot.....again.